FUSN (FUSN:NASDAQ) jumped higher at $9.64, a gain of 18.1%. On Mon, Jun 14, 2021, FUSN:NASDAQ touched a New 2-Week Intraday Low of $8.08. The stock appeared on our News Catalysts scanner on Mon, Jun 14, 2021 at 05:05 PM in the 'BIOTECH' category. From Tue, Jun 01, 2021, the stock recorded 55.56% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About FUSN (FUSN:NASDAQ)
Fusion Pharmaceuticals Inc is a clinical stage bio-pharmaceutical company focused on developing alpha therapeutics for curing cancer.
Top 10 Gainers:
- ALF (ALF:NASDAQ), 104.4%
- Torchlight Energy Resources, Inc. (TRCH:NASDAQ), 41.62%
- Clearside Biomedical, Inc. (CLSD:NASDAQ), 37.75%
- Unique Fabricating, Inc. (UFAB:NYSEMKT), 37.31%
- HMG/Courtland Properties, Inc. (HMG:NYSEMKT), 25.21%
- FOA (FOA:NYSE), 21.78%
- TDH Holdings, Inc. (PETZ:NASDAQ), 18.96%
- FUSN (FUSN:NASDAQ), 18.14%
- Citius Pharmaceuticals, Inc. (CTXR:NASDAQ), 17.45%
- GOEV (GOEV:NASDAQ), 16.81%